IL6 and neoplasm: Thus, combinatorial approaches through multispecific antibodies targeting multiple pathways might encourage redefining and reprogramming the TME to efficaciously eradicate tumours, and inhibiting TAM-derived IL-6-mediated signalling transduction pathways.